trending Market Intelligence /marketintelligence/en/news-insights/trending/knxn4latsn4vug4wklbjpg2 content esgSubNav
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

UK's Realm Therapeutics to list American depositary shares on Nasdaq

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


UK's Realm Therapeutics to list American depositary shares on Nasdaq

Realm Therapeutics PLC, a U.K. developer of topical medicines for skin conditions, is listing its American depositary shares on the Nasdaq Stock Market.

The ADSs will begin trading this month under the ticker RLM.

The London-based company will list 126,857,901 ordinary shares, represented by about 5,074,316 ADSs. Each ADS represents 25 ordinary shares, with a nominal value of 10 pence per share.

Realm said it will not receive proceeds from the transaction.